Xueke Wang et al. found that the combination of an inhibitory signal transducer and activator of transcription 3 (STAT3) and NDV enhanced ICD in NDV-induced PCa, thereby enhancing anti-tumor immunity and improving NDV-based anti-PCa effects [231]. The gene discussed is STAT3; the disease is neoplasm.